The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Compare Best Stocks
Sara Nik's Stock Ratings
HC Wainwright & Co. Analyst
Sara Nik is an analyst at HC Wainwright & Co.. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025
Updated: Dec 15, 2025
Overall Average Return
67.2%
Smart Score
Overall Average Return Percentile
96th
Number of Ratings
9
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 12/11/2025 | MBRX | Buy Now | Moleculin Biotech | $5.00 | 340% | $4 → $22 | Maintains | Buy | Get Alert | |
| 12/08/2025 | KTTA | Buy Now | Pasithea Therapeutics | $1.13 | 165.37% | → $3 | Initiates | → Buy | Get Alert | |
| 11/14/2025 | CDTX | Buy Now | Cidara Therapeutics | $220.25 | — | — | Downgrade | Buy → Neutral | Get Alert | |
| 10/21/2025 | CDTX | Buy Now | Cidara Therapeutics | $220.25 | -31.9% | $150 → $150 | Reiterates | Buy → Buy | Get Alert | |
| 10/09/2025 | CDTX | Buy Now | Cidara Therapeutics | $220.25 | -31.9% | $110 → $150 | Maintains | Buy | Get Alert | |
| 09/26/2025 | CDTX | Buy Now | Cidara Therapeutics | $220.25 | -50.06% | $74 → $110 | Maintains | Buy | Get Alert | |
| 09/10/2025 | MBRX | Buy Now | Moleculin Biotech | $5.00 | -20% | $4 → $4 | Reiterates | Buy → Buy | Get Alert | |
| 08/27/2025 | MBRX | Buy Now | Moleculin Biotech | $5.00 | -20% | $4 → $4 | Reiterates | Buy → Buy | Get Alert | |
| 08/08/2025 | CDTX | Buy Now | Cidara Therapeutics | $220.25 | -66.4% | $53 → $74 | Maintains | Buy | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved